Lexotan

Bromazepam, the active ingredient in Lexotan, is a benzodiazepine presented as an oral dosage form for oral use. It is prescribed for anxiety disorders, short‑term relief of anxiety symptoms, and insomnia related to anxiety.

GNH USA supplies Lexotan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bromazepam acts on the central nervous system to alleviate anxiety‑related conditions. - Anxiety disorders: reduces excessive worry, tension and physiological symptoms of anxiety. - Short‑term relief of anxiety symptoms: provides rapid calming effect during acute stress episodes. - Insomnia related to anxiety: improves sleep onset by diminishing anxiety‑driven arousal.

Bromazepam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: light‑headed sensation, especially when standing quickly. - Impaired coordination: reduced motor control and balance. - Memory impairment: difficulty recalling recent events. - Fatigue: general lack of energy. - Gastrointestinal discomfort: nausea or upset stomach.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, especially with other depressants. - Severe allergic reactions: rash, itching, swelling, or difficulty breathing. - Dependence and withdrawal: risk of physical dependence with prolonged use, leading to withdrawal symptoms upon abrupt cessation. - Paradoxical reactions: increased anxiety, agitation, or aggression in rare cases. - Depression or suicidal thoughts: emergence or worsening of mood disturbances. - Hepatic dysfunction: abnormal liver enzyme elevations.

Bromazepam requires careful consideration of patient‑specific factors and safe handling practices. - Assess renal and hepatic function: adjust use if organ impairment is present. - Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal. - Use caution in elderly patients: increased sensitivity to sedation and falls. - Avoid concomitant alcohol or CNS depressants: heightened risk of excessive sedation. - Pregnancy and lactation: discuss risks with a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Bromazepam can interact with other substances that affect the central nervous system or its metabolism.

Major Interactions (Avoid): - Opioids, barbiturates, or other benzodiazepines: risk of profound sedation and respiratory depression. - Alcohol: additive central nervous system depression leading to marked drowsiness. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase bromazepam plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., carbamazepine, rifampicin): may reduce therapeutic effect. - Antidepressants (e.g., SSRIs, SNRIs): can enhance sedative properties. - Antihistamines: may increase drowsiness and impair coordination.